When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RUBY - Rubius Therapeutics up 34% after insider buy
Rubius Therapeutics Inc.
Shares of Rubius Therapeutics (NASDAQ:RUBY) are up 34% on Monday following the SEC filing of a purchase by a member of the company's board of directors. The filing shows that on April 21, David Epstein bought 30K shares at an average price of $1.44, for a total purchase price of $43,329. Epstein now owns a total of ~4.72M shares. Seeking Alpha's Quant Rating gives Rubius (RUBY) a strong sell rating.